SEAR 2014 - origin.searo.who.intorigin.searo.who.int/entity/immunization/data/epi_factsheet_searo_2… · SEAR 2014 Immunization and Vaccine Development South-East Asia Region World

SEAR 2014

Immunization andVaccine Development

South-East Asia Region

World Health Organization• SEARO/FHR/IVD • 22 July 2015

The Immunization and Vaccine Development (IVD) unit of the Department of Family Health and Research (FHR), World Health Organization (WHO), Regional Office for South-East Asia (SEARO) has been producing annually the Expanded Programme on Immunization (EPI) fact sheets since 2002 for all SEA countries and the region. The 2014 EPI fact sheets are the thirteenth annual

publication. The primary data source of the EPI fact sheets are the WHO-UNICEF joint reporting form (JRF) and SEARO annual EPI reporting form (AERF) in which each country officially reports EPI and vaccine preventable diseases (VPD) related core information annually.

Figure 1: SEAR population density by first administrative level*, 2014

Source: Annual EPI reporting form 2014.

*Population density by second administration level for Bhutan, Sri Lanka and Timor-Leste.

Source: Annual EPI reporting form 2013 a District & city b Township1 WHO, World Health Statistics 2014; India-SRS 2013; Sri Lanka - Census & Statistics Department and MOH;

Table 1: Basic information, 2014

Country

2014 population Mortality1 Administrative levels

Total population Live births Under 1 year Under 5

years

Under 15

years

Neonatal mor-

tality rate (per

1,000 LB)

"Infant mortali-

ty rate

(per 1,000 LB)"

Under-5 mor-

tality rate (per

1,000 LB)

Maternal

mortatlity ratio

(per 100,000 LB)

Number of

province /region /

division

Number of

district

Bangladesh 156,012,726 3,525,888 3,374,274 16,381,336 53,980,403 24 33 41 170 7 64

Bhutan 745,153 13,338 12,938 89,418 230,997 21 36 45 120 - 20

DPR Korea 24,759,000 342,458 337,950 1,698,664 5,233,093 16 23 29 87 12 210

India 1,265,308,000 27,016,000 25,928,200 ND 432,037,331 29 42 52 178 36 674

Indonesia 252,124,458 4,809,304 4,665,025 24,085,400 ND 15 26 31 190 34 511a

Maldives 341,848 7,739 7,028 33,931 89,307 6 9 11 31 - 20

Myanmar 51,419,420 958,495 928,960 4,584,847 13,709,745 26 41 52 200 17 330b

Nepal 27,311,978 662,285 628,824 2,808,179 9,941,560 24 34 42 190 5 75

Sri Lanka 20,675,000 349,715 346,253 1,778,050 5,210,100 6.8 9.2 10.4 37.7 9 26

Thailand 64,875,909 780,197 733,412 3,841,366 11,884,129 8 11 13 26 77 928

Timor-Leste 1,212,110 43,924 40,351 192,340 510,594 24 48 57 270 - 13

SEAR 1,864,785,602 - 37,003,215 - 532,827,259 27 39 50 190 - -

Disclaimer: The boundaries and names shown and the designations used on all the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

E P I F A C T S H E E T


2

Source: WHO/UNICEF JRF 2014 W=Week M=Month Y=Year

Reference labs

Polio (global specialized)

Measles and rubella

Japanese encephalitis

IBD reference

Rota reference

National labs

Polio

Measles and rubella

Japanese encephalitis

IBD

Rota

Sub-national measles lab

Table 2: Routine immunization schedule, 2014

Country BCG DTP HepB MCV OPV TT Vitamin A Other vaccinations

Bangladesh At birth

DTPHibHepB - 6W, 10W, 14WMR-38W, 15Y (Female) Measles-15M

6W, 10W, 14W, 38W IPV-14W (March 2015)

Females 15Y to 49Y (5 doses with an interval of + 1 month, + 6 months, + 1 year and + 1 year with preceding dose)

6-59MPneumo_conj (March 2015)

BhutanAt birth

HepB- At birth DTPHibHepB - 6W, 10W, 14W DTP-24M

MR- 9M, 24MAt birth, 6W, 10W, 14W IPV-14W (Jul 2015)

Td-6Y, 12Y, pregnant women (2 doses for primi-gravidarum, and 1 dose for subsequent pregnancies)

6-59MHPV-Females 12 years + (0, 2 and 6 months)

DPR KoreaAt birth

HepB- At birth DTPHibHepB - 6W, 10W, 14W

Measles-9M, 15M6W, 10W, 14W IPV-14W (Apr 2015)

Td - 3M, 4M pregnant women 6-59M -

IndiaAt birth

HepB - At birth, 6W, 10W, 14W DTP - 6W, 10W, 14W, 16-24M, 5-6Y DTPHibHepB - 6W, 10W, 14W (selected states)

Measles-9-12M, 16-24M

At birth, 6W, 10W, 14W, 16-24M

10Y and 16Y, 2 doses/booster for pregnant women

9 months, 18 months and 6 months interval till age 5 years

JE - 9-12M and 16-24M (JE endemic districts)

Indonesia 1MHepB- 0-7 day of birth DTPHibHepB - 2M, 3M, 4M, 18M

Measles-9M, 24 M, Grade 1 (6Y)

1M, 2M, 3M, 4M (IPV-2M, 3M, 4M in selected province)

TT- 15Y to 39Y female DT - 6Y (1st grade) Td- 7Y (2nd grade), 8Y (3rd grade)

6-59M

MaldivesAt birth

HepB-At birth DTPHibHepB - 2M, 4M, 6M

Measles-9M MMR - 18M

At birth, 2M, 4M, 6M IPV-6M (Mar 2015)

Td - Females 15Y-45Y, +1M, +6M, +1Y, +1Y

9-59M

MyanmarAt birth

HepB- At birth DTPHibHepB - 2M, 4M, 6M

Measles-9M, 18M 2M, 4M, 6MFirst contact during pregnancy, +1M

6-59M -

NepalAt birth

DTPHibHepB - 6W, 10W, 14WMR-9M MR-15 M (Jul 2015)

6W, 10W, 14W IPV-14W (Sep 2014)

During pregnancy 6-59MJE_LiveAtd - 12-23M (high-risk districts)

Sri LankaAt birth

DTPHibHepB - 2M, 4M, 6M DTP - 18M

MMR - 1Y, 3Y2M, 4M, 6M, 18M, 5Y

DT - 5Y Td - 12Y TT - Pregnant women (2 doses in 1st pregnancy and 1 dose in subsequent 3 pregnancies)

6-59MJE_LivtAtd - 9M Typhoid - high risk groups

ThailandAt birth

HepB - At birth, 1M (new-born from HepB carrier mother) DTPHepB - 2M, 4M, 6M DTP - 1.5-2Y, 4-5Y

MMR - 9M, school children grade 1

2M, 4M, 6M, 1.5-2Y, 4-5Y

Td - School children grade VI and pregnant women 1st contact, +1M, +6M (depend on vaccination history)

-

JE_Inactd - 1.5-2Y (2 doses 4 weeks apart), 2.5-3Y Rotavirus- 2m, 4M (pilot only in Sukhothai province)

Timor-LesteBirth to 1Y

DTPHibHepB - 6W, 10W, 14W DTP-18M (Sep 2015)

Measles-9M MR-9M, 18 M (Sep 2015)

Birth to 2W, 6W, 10W, 14W IPV-14W (Sep 2015)

Females 15Y-49Y (1st pregnancy contact, +1M, +6M, +1Y, +1Y) DT-5Y (Sep 2015)

6-59M -

Figure 2: SEAR laboratory network, 2014



3

Country Year of 1st NIDs Total NIDs rounds

Last NID round SNIDs in 2014 Last case of wild polio

Bangladesh 1995 40 Dec-13 No 22-Nov-06

Bhutan 1995 2 Nov-95 No 1986*

DPR Korea 1997 12 Nov-02 No 1996

India 1995 38 Feb-14 Yes 13-Jan-11

Indonesia 1995 13 Apr-06 No 20-Feb-06

Maldives 1996 8 Jan-01 No 1994

Myanmar 1996 22 Feb-09 Yes 28-May-07

Nepal 1996 27 Jan-14 No 30-Aug-10

Sri Lanka 1995 8 Dec-00 No Nov-93

Thailand 1994 10 Jan-00 Yes Apr-97

Timor-Leste 1995** 12 Sep-05 No 1995

* Clinically confirmed polio ** SIA conducted with Indonesia.

Table 5: NID/SNID and date of last polio case, 1995-2014

Table 3: Routine immunization coverage estimates, 2010-2014

Table 4: Reported vaccine preventable diseases, 2012-2014

Country

2012 2013 2014

Polio

Diph

ther

ia

Pertu

ssis

Tota

l tet

anus

(N

NT)

Mea

sles

Rube

lla

Mum

ps

JE Polio

Diph

ther

ia

Pertu

ssis

Tota

l tet

anus

(N

NT)

Mea

sles

Rube

lla

Mum

ps

JE Polio

Diph

ther

ia

Pertu

ssis

Tota

l tet

anus

(N

NT)

Mea

sles

Rube

lla

Mum

ps

JE

Bangladesh 0 16 13 614 (109) 1986 3245 ND 52 0 2 1 508 (108) 237 3034 ND 23 0 13 12 ND 289 381 ND 183

Bhutan 0 0 0 0 (0) 1 2 198 0 0 0 0 0 0 6 20 0 0 0 0 4 (0) 0 0 206 2

DPR Korea 0 0 8 0 (0) 0 1 11 0 0 0 0 0 0 0 0 0 0 0 0 0 (0) 3 0 0 0

India 0a 2525 44154 2404 (588) 18668 1232 ND ND 0c 3133 31089 2814 (415) 13822 3698 ND 1078 0d 6094 46706 5017 (492) 24977 4870 0 1657

Indonesia 0 1192 ND ND (106) 15489 1020 ND ND 0 775 2976 225 (69) 8419 2355 ND ND 0 421 2082 1023 (75) 12222 3267 ND 72

Maldives 0 0 0 0 (0) 0 0 14 0 0 0 0 0 0 0 17 0 0 0 0 0 (0) 0 0 0 0

Myanmar 0b 19 2 75 (29) 2175 21 ND 14 0 38 14 73 (39) 1010 23 ND 3 0 29 5 73 (32) 122 30 ND 50

Nepal 0 138 1595 359 (32) 3362 801 35874 75 0 103 3431 377 (87) 1861 755 29134 118 0 1079 6096 ND (57) 1279 704 34034 1304

Sri Lanka 0 0 61 8 (0) 51 54 3558 60 0 0 67 19 2107 24 1274 70 0 0 38 9 (0) 1686 10 383 21

Thailand 0 63 14 105 (4) 5197 493 7431 54 0 28 24 126 (2) 2641 539 5907 59 0 ND ND ND ND ND ND ND

Timor-Leste 0 0 0 10 (4) 16 8 0 0 0 1 0 11 (1) 4 0 ND 5 0 2 0 0 47 1 0 0

SEAR 0 3953 45847 3575 (872) 46945 6877 47086 255 0 4080 37602 4153 (721) 30101 10434 36352 1356 0 7638 54939 6126 (656) 40625 9263 34623 3289

Country

BCG DTP3 OPV3 MCV

2010 2011 2012 2013 2014 2010 2011 2012 2013 2014 2010 2011 2012 2013 2014 2010 2011 2012 2013 2014

Bangladesh 98 99 99 99 99 94 95 95 95 95 94 95 95 95 95 88 89 89 89 89

Bhutan 96 95 95 97 99 91 95 97 97 99 92 95 97 97 98 95 95 95 94 97

DPR Korea 98 98 98 98 98 93 94 96 93 93 99 99 99 99 99 99 99 99 99 99

India 89 90 90 91 91 79 82 82 83 83 76 79 79 82 82 82 84 83 83 83

Indonesia 88 98 99 98 93 81 81 83 85 78 82 81 84 86 79 78 80 85 84 77

Maldives 97 98 99 99 99 96 96 99 99 99 97 96 99 99 99 97 96 98 99 99

Myanmar 93 93 87 86 86 90 84 84 75 75 90 90 87 76 76 88 88 84 86 86

Nepal 94 97 96 97 99 82 92 90 92 92 83 92 90 92 92 86 88 86 88 88

Sri Lanka 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99

Thailand 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 98 98 98 99 99

Timor-Leste 71 68 71 82 79 72 67 83 82 77 72 66 83 82 76 66 62 73 70 74

SEAR 90 92 92 93 92 82 84 84 85 84 80 82 82 84 83 83 85 84 84 84

Source: WHO/UNICEF coverage estimates 2013 revision (July 2014). For 2014 country official estimates are used.

a Excludes 1 VPDV (type 2) b Excludes 1 VDPV (type 1) c Excludes 5 VDPV (type 2) d Excludes 3 VDPVs (Type 2)Source: WHO/UNICEF JRF ND=No data

Figure 3: Last wild polio case by type in SEARWPV type 2, Uttar Pradesh, India, 1999

WPV type 3, Jharkhand, India, 2010

WPV type 1, West Bengal, India, 2011



4

Table 6: AFP surveillance indicators by country, 2012-2014

Country

2012 2013 2014

AFP Wild

polio

Non-polio

AFP rate

Adequate stool

specimen

collection (%)

AFP Wild

polio

Non-polio

AFP rate

Adequate stool

specimen

collection (%)

AFP Wild

polio

Non-polio AFP

rate

Adequate stool

specimen

collection (%)

Bangladesh 1,567 0 2.98 96 1,412 0 2.65 96 1,478 0 2.74 98

Bhutan 10 0 5.14 70 10 0 4.52 80 11 0 4.84 73

DPR Korea 125 0 2.18 100 116 0 2.02 100 115 0 2.00 100

India 60,922 0 13.94 87 54,660 0 12.48 86 54,101 0 12.37 87

Indonesia 1,951 0 2.76 92 1,963 0 2.74 91 1,765 0 2.43 89

Maldives 4 0 4.55 75 1 0 1.08 100 1 0 1.12 100

Myanmar 457 0 2.21 97 404 0 1.91 95 389 0 1.82 96

Nepal 640 0 6.12 95 576 0 5.76 94 486 0 4.85 95

Sri Lanka 75 0 1.54 80 103 0 1.66 82 85 0 1.61 74

Thailand 289 0 2.21 74 235 0 1.80 70 238 0 1.97 79

Timor-Leste 5 0 1.00 40 5 0 1.61 20 3 0 0.59 67

SEAR 66,045 0 10.72 87 59,485 0 9.60 87 58,672 0 9.45 87

Figure 4: AFP surveillance indicators by first administrative level1, 2014

*Number of discarded AFP cases per 100,000 children under 15 years of age. *Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.1 Bhutan, Maldives & Timor-Leste by Country.

0

10

20

30

40

50

60

70

AF

P c

ases

in T

ho

usa

nd

s

India SEAR excluding India

Year

AFP cases

SEAR excluding India

India Total

1997 1,503 3,047 4,550

1998 2,387 9,465 11,852

1999 2,329 9,587 11,916

2000 2,655 8,103 10,758

2001 3,143 7,470 10,613

2002 3,195 9,705 12,900

2003 2,781 8,508 11,289

2004 2,996 13,274 16,270

2005 4,481 27,049 31,530

2006 4,471 32,194 36,665

2007 4,600 41,524 46,124

2008 4,927 45,582 50,509

2009 4,557 50,405 54,962

2010 4,670 55,782 60,452

2011 4,791 60,540 65,331

2012 5,123 60,922 66,045

2013 4,825 54,660 59,485

2014 4,571 54,101 58,672

Figure 5: Number of annual AFP cases reported in SEAR, 1997-2014

Non-polio AFP rate* % Adequate Stool Specimen Collection*

Enhanced surveillance initiated

Non-polio AFP rate< 11 – 1.99> 2No non-polio AFP case

Non-polio AFP rate< 11 – 1.99> 2No non-polio AFP case

Adequate stoolcollection rate

< 60%60% – 79%> 80%No AFP case

Adequate stoolcollection rate

< 60%60% – 79%> 80%No AFP case



5

Figure 6: OPV3 coverage by country, 2010-2014 Figure 7: DTP3 coverage by country, 2010-2014*

0

20

40

60

80

100

Bang

lade

sh

Bhut

an

DPR

Kor

ea

Indi

a

Indo

nesi

a

Mal

dive

s

Mya

nmar

Nep

al

Sri L

anka

Thai

land

Tim

or-L

este

% C

over

age

2010 2011 2012 2013 2014

0

20

40

60

80

100

Bang

lade

sh

Bhut

an

DPR

Kor

ea

Indi

a

Indo

nesi

a

Mal

dive

s

Mya

nmar

Nep

al

Sri L

anka

Thai

land

Tim

or-L

este

% C

over

age

2010 2011 2012 2013 2014

Source: WHO/UNICEF coverage estimates 2014. Source: WHO/UNICEF coverage estimates 2014.

Figure 8: Districts achieving >80% DTP3 coverage by country, 2010-2014

Figure 9: DTP1-DTP3 drop-out by country, 2010-2014

2010 20142011 2012 2013

0

20

40

60

80

100

Bang

lade

sh

Bhut

an

DPR

Kor

ea

Indi

a

Indo

nesi

a

Mal

dive

s

Mya

nmar

Nep

al

Sri L

anka

Thai

land

*

Tim

or-L

este

% o

f Dis

tric

ts

2010 20142011 2012 2013

% D

ropo

ut

0

2

4

6

8

10

12

14

16

18

20

Bang

lade

sh

Bhut

an

DPR

Kor

ea

Indi

a

Indo

nesi

a

Mal

dive

s

Mya

nmar

Nep

al

Sri L

anka

Thai

land

Tim

or-L

este

Source: WHO/UNICEF JRF * district level data not reportedSource: WHO/UNICEF coverage estimates 2014.

Figure 10: HepB vaccine introduction and HepB3 coverage, 2014

Country HepB3 coverage

2009 2010 2011 2012 2013 2014

Bangladesh 97 94 95 95 95 95

Bhutan 93 91 95 97 97 99

DPR Korea 93 93 94 96 93 93

India 37 38 44 73 70 70

Indonesia 82 83 81 83 85 78

Maldives 98 97 96 99 99 99

Myanmar 91 92 40 58 75 75

Nepal 89 82 92 90 92 92

Sri Lanka 97 99 99 99 99 99

Thailand 98 98 98 98 99 99

Timor-Leste 72 72 67 83 82 77

SEAR 53 53 56 77 76 75Source: WHO/UNICEF coverage estimates 2014

DTP HepB Hib (Pentavalent) DTP HepB Tetra/Mono HepB

Note: Pentavalent implemented in eight states of India



6

Figure 12: MCV1 coverage by country, 2010-2014 Figure 13: Percent of districts achieving >80% MCV1 coverage by country, 2010-2014

Source: Annual EPI reporting form (administrative data), 2014

*Bhutan, Maldives & Timor-Leste by country Bangladesh coverage evaluation data (2014)

< 70% 70% - 79% 80% - 89%

No data≥ 90%

Table 7: Suspected measles cases and outbreaks by country, 2014

Country

Routine reporting of clinically suspected measles

cases

Suspected measles outbreaks Classification of outbreaks1

Cases Deaths Tested for

serology

Serology

+ve

measles

Serology

+ve

rubella

Number

of

outbreaks

Number of

outbreaks

investigated*

Number

of cases

Deaths Lab confirmed

measlesLab confirmed rubella

Lab confirmed mixed

(measles and rubella)

Number of

outbreaks

Number

of cases

Number of

outbreaks

Number

of cases

Number of

outbreaks

Number

of cases

Bangladesh 1,668 0 1,607 97 176 71 71 1,368 0 9 178 11 166 2 31

Bhutan 69 0 69 0 4 0 0 0 0 0 0 0 0 0 0

DPR Korea 11 0 11 0 0 0 0 0 0 0 0 0 0 0 0

India 54,193 110 - - - 1,692 1,012 34,739 101 767 26,044 110 4,993 - -

Indonesia 12,943 7 5,719 1,471 713 173 108 2104 21 80 803 7 69 3 13

Maldives 0 0 9 0 0 0 0 0 0 0 0 0 0 0 0

Myanmar 242 0 242 8 24 7 7 236 0 3 102 1 5 0 0

Nepal 350 1 292 9 14 2 2 18 0 0 0 0 0 0 0

Sri Lanka 3,117 0 2,123 1,560 10 1 1 10 0 0 0 1 10 0 0

Thailand 1,191 0 427 70 19 0 0 0 0 0 0 0 0 0 0

Timor-Leste 47 1 40 25 1 2 2 33 1 2 20 0 0 0 0

Total 73,831 119 10,539 3240 961 1,948 1,203 38,508 123 861 27,147 130 5,243 5 44

1 At least 5 blood samples should be collected and tested from each outbreak. ND=No data* Total suspected outbreaks may not add to total lab confirmed outbreaks because some outbreak samples are in process with results pending and/or outbreak reports are not received from the field (investigation in process).

Figure 11: DTP3 immunization coverage by first administrative level*, 2014

2010 20142011 2012 2013

% C

over

age

Bang

lade

sh

Bhut

an

DPR

Kor

ea

Indi

a

Indo

nesi

a

Mal

dive

s

Mya

nmar

Nep

al

Sri L

anka

Thai

land

Tim

or-L

este

0

20

40

60

80

100

% o

f Dis

tric

ts

0

20

40

60

80

100

Bang

lade

sh

Bhut

an

DPR

Kor

ea

Indi

a

Indo

nesi

a

Mal

dive

s

Mya

nmar

Nep

al

Sri L

anka

Thai

land

*

Tim

or-L

este

2010 2011 2012 2013 2014

Source: WHO/UNICEF coverage estimates 2014. Source: WHO/UNICEF JRF *district level data not reported



7

Introduced

Planned in 2015

Figure 14: Measles second dose through routine immunization, 2014

Country Laboratories Number of serum

samples received

Number tested for

measles & rubella

Positive results1 % Measles results

reported with in 7 days

Date of last report received

in SEAROMeasles Rubella

# % # %

Bangladesh Dhaka 2,051 1,992 143 7.2 221 12.0 99.6 8-Jan-15

Bhutan Thimphu 69 61 0 0.0 4 6.6 77.0 8-Jan-15

DPR Korea Pyongyang 55 55 2 3.6 0 0.0 100.0 3-Jul-14

India

Ahmedabad 468 468 306 65.4 25 15.4 99.6 12-Jan-15

Bengaluru 528 381 258 67.7 27 22.0 93.7 6-Jan-15

Bhopal 212 212 134 63.2 21 26.9 63.7 12-Jan-15

Chennai 796 263 150 57.0 20 17.7 86.7 9-Jan-15

Guwahati 74 74 28 37.8 32 69.6 95.9 10-Jan-15

Hyderabad 138 138 103 74.6 3 8.6 95.7 2-Jan-15

Jaipur 289 289 205 70.9 17 20.2 95.2 9-Jan-15

Kolkata 1,386 1,386 752 54.3 281 44.3 0.0 3-Feb-15

Lucknow 683 623 496 79.6 15 11.8 62.8 16-Jan-15

Patna 171 171 117 68.4 11 20.4 66.7 12-Dec-14

Pune 889 869 570 65.6 38 12.7 91.6 13-Jan-15

Total 5,634 4,874 3,119 64.0 490 27.9 60.8

Indonesia

Bandung 902 902 369 40.9 231 43.3 96.1 12-Jan-15

Jakarta 4,083 4,027 1,558 38.7 531 21.5 65.7 12-Jan-15

Surabaya 2,860 2,857 1,718 60.1 189 16.6 44.5 12-Jan-15

Yogyakarta 2,643 2,643 661 25.0 394 19.9 58.3 12-Jan-15

Total 10,488 10,429 4,306 41.3 1345 22.0 60.6

Maldives Male 695 695 0 0.0 3 0.4 100.0 12-Jan-15

Myanmar Yangon 282 282 24 8.5 29 11.2 83.3 12-Feb-15

Nepal Kathmandu 328 328 8 2.4 15 4.7 97.3 10-Jan-15

Sri Lanka Colombo 2,080 2,054 1,496 73 10 2 87 7-Jan-15

Thailand Bangkok 147 147 12 8.2 8 5.9 100.0 5-Jan-15

Timor-Leste Dilli ND SEAR Total 21,829 20,917 9,110 43.6 2,125 18.0 69.6

Source: Reported by SEAR Measles Laboratory Network ND=No Data

Table 8: Measles and rubella laboratory network serology results, 2014





Figure 15: TT2+ coverage by country, 2010-2014

For contact or feedback: Immunization and Vaccine Development (IVD), Department of Family Health and ResearchWorld Health Organization, Regional Office for South East Asia, IP Estate, Mahatma Gandhi Marg, New Delhi 110002, IndiaTel: +91 11 23370804, Fax: +91 11 23370251, Email: [email protected], www.searo.who.int/entity/immunization

2010 20142011 2012 2013

% C

over

age

0102030405060708090

100

Bang

lade

sh

Bhut

an

DPR

Kor

ea

Indi

a

Indo

nesi

a

Mal

dive

s

Mya

nmar

Nep

al

Sri L

anka

Thai

land

Tim

or-L

este

Figure16: Neonatal tetanus elimination status*

Source: WHO/UNICEF JRF

*India & Indonesia by province (As of April 2015)

Elimination validated

Elimination not validated or planned

Conducted or planned SIA to reach MNT elimination

Table 9: Planning and management indicators, 2014

Country

Multi year plan (MYP) for immunization

Annual work plan

Standing technical advisory group on

immunization

Number and percentage of districts with updated micro-plans to raise immunization coverageYears covered by

MYPCosting is included

Country has an annual workplan for immunization

activities in 2013

Costing is included

Bangladesh 2011-2016 Yes Yes Yes Yes 64 (100%)

Bhutan 2014-2018 Yes Yes Yes Yes 20 (100%)

DPR Korea 2011-2015 Yes Yes Yes Yes 210 (100%)

India 2013-2017 Yes Yes Yes Yes 674 (100%)

Indonesia 2015-2019 Yes Yes Yes Yes 179 (35%)

Maldives 2009-2013 Yes Yes Yes Yes 20 (100%)

Myanmar 2012-2016 Yes Yes Yes Yes 330 (100%)

Nepal 2011-2016 Yes Yes Yes Yes 75 (100%)

Sri Lanka 2011-2016 Yes Yes Yes Yes 26 (100%)

Thailand 2013-2016 Yes Yes Yes Yes 928 (100%)

Timor-Leste 2013-2015 Yes Yes Yes No 13 (100%)

Source: WHO/UNICEF JRF ND=No data

Table 10: Vaccine safety and immunization financing, 2014

Country

Activities being implemented Adverse events following immunization (AEFI) Government financed on

Immunization injection safety Waste management National system to monitor

AEFI

No. AEFI Reported % of all spending on

vaccines

% of all spending on

routine immunization

Bangladesh Yes Yes Yes 3,486 56% 53%

Bhutan Yes Yes Yes 18 31% ND

DPR Korea Yes Yes Yes 1 7% 48%

India Yes Yes Yes 778 78% 78%

Indonesia Yes Yes Yes 104 78% 64%

Maldives Yes Yes Yes 2 100% 100%

Myanmar Yes Yes Yes 34 ND ND

Nepal Yes Yes Yes 19 29% 22%

Sri Lanka Yes Yes Yes 6,957 94% 93%

Thailand Yes Yes Yes 844 100% 100%

Timor-Leste Yes Yes Yes 0 81% 39%

Source: WHO/UNICEF JRF ND=No Data

Documents

SEAR 2014 - origin.searo.who.intorigin.searo.who.int/entity/immunization/data/epi_factsheet_searo_2… · SEAR 2014 Immunization and Vaccine Development South-East Asia Region World